Azfar Zaman

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

Timo Mäkikallio, Niels Ramsing Holm, Mitchell Lindsay et al. · The Lancet · 2016 · 758 citations · Full text

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +7

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

Niels Ramsing Holm, Timo Mäkikallio, Mitchell Lindsay et al. · The Lancet · 2019 · 424 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +10

Atrial Fibrillation After Coronary Artery Bypass Surgery

Azfar Zaman, Andrew Archbold, Gérard Helft et al. · Circulation · 2000 · 314 citations · Full text

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 289 citations · Full text